Frazier Financial Advisors »

Atea Pharmaceuticals shares owned by Frazier Financial Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Frazier Financial Advisors from 13F filings

Historical chart of Frazier Financial Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Frazier Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Frazier Financial Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $366 120 3.05

More positions owned by Frazier Financial Advisors

Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Currncy Int Eq (DDWM)
Wisdomtree Tr Us Midcap Divid (DON)
Wisdomtree Tr Us Smallcap Divd (DES)
Abbott Laboratories (ABT)
Vanguard Index Fds Small Cp Etf (VB)
Abbvie (ABBV)
Accenture Plc Ireland Shs Class A (ACN)
Apple (AAPL)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
Bath &#38 Body Works In (BBWI)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Microsoft Corporation (MSFT)

View all positions for Frazier Financial Advisors

Top funds holding Atea Pharmaceuticals

EcoR1 Capital
BML Capital Management
Vanguard Group
Tang Capital Management
Federated Investors
Charles Schwab Investment Management
Jacobs Levy Equity Management
Newtyn Management
Banque Pictet & Cie Sa
Two Sigma Advisers
CM Management
Bank of America Corporation
Bank of New York Mellon
Goldman Sachs Group
Barclays

View all funds holding Atea Pharmaceuticals